News

AliveCor, recently recognized as the Most Innovative Company in Artificial Intelligence, announced that the U.S. Food and Drug Administration has given the company's KardiaK Software Platform the rarely granted designation of "Breakthrough...

PhysIQ, a leader in applying AI analytics to biosensor data, announced it has received FDA 510(k) clearance for its atrial fibrillation (AFib) detection analytics engine. The clearance extends physIQ’s portfolio of FDA 510(k) cleared...

Cardiac Insight, Inc., a leading U.S. developer of wearable biosensors and diagnostic software systems featuring proprietary automated data analysis algorithms, announced that its wearable ECG Sensor, Cardea SOLO, continues to attract...

Correvio Pharma Corp., a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients, reported preliminary data from SPECTRUM, a...

SentreHEART, Inc., manufacturer of the LARIAT® Suture Delivery Device (LARIAT) for percutaneous left atrial appendage (LAA) closure, announced enrollment of the 400th patient in the prospective, multicenter, randomized controlled Trial known...

Chicago-based medical device firm Attune Medical has completed the final close of its Series C raise, now oversubscribed to total more than $15.5 million. This financing will be used to ensure Attune’s continued revenue growth in the...

Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures. The...

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation (AFib) and left atrial appendage management, announced it has completed enrollment of the full cohort of 153 patients in the CONVERGE IDE clinical trial. The...

BIOTRONIK announced that the company is now the exclusive U.S. distributor for InfoBionic's MoMe Kardia external cardiac diagnostic monitor. The device benefits patients suspected of experiencing cardiac arrhythmias. Patients experiencing...

Advanced Cardiac Therapeutics, Inc. (ACT), a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AFIB), announced it has changed its name to EPIX Therapeutics,...